Published in J Bone Miner Res on May 01, 2003
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol (2005) 2.00
Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. PLoS One (2010) 1.29
Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging. Aging Cell (2012) 1.07
Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res (2010) 0.97
Pannexin 3 inhibits proliferation of osteoprogenitor cells by regulating Wnt and p21 signaling. J Biol Chem (2013) 0.89
The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth Arrest. PLoS One (2015) 0.79
New insights in osteogenic differentiation revealed by mass spectrometric assessment of phosphorylated substrates in murine skin mesenchymal cells. BMC Cell Biol (2013) 0.79
Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation. J Bone Miner Res (2013) 0.76
DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age. Aging Cell (2017) 0.76
The Role of Pannexin 3 in Bone Biology. J Dent Res (2016) 0.75
Common mechanisms in development and disease: BMP signaling in craniofacial development. Cytokine Growth Factor Rev (2015) 0.75
Disruption of the Aldehyde Dehydrogenase 2 Gene Results in No Increase in Trabecular Bone Mass Due to Skeletal Loading in Association with Impaired Cell Cycle Regulation Through p21 Expression in the Bone Marrow Cells of Mice. Calcif Tissue Int (2017) 0.75
Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev (2005) 3.28
Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell (2007) 2.14
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol (2005) 2.00
Retracted A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J (2005) 1.72
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc Natl Acad Sci U S A (2004) 1.70
Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol (2003) 1.50
Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J Cell Physiol (2008) 1.46
A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol (2003) 1.39
Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J (2002) 1.27
Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Dev Biol (2009) 1.24
Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J Biol Chem (2003) 1.20
Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res (2003) 1.16
Fibroblast growth factors share binding sites in heparan sulphate. Biochem J (2005) 1.15
FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J Cell Biol (2002) 1.11
PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS One (2008) 1.07
SOX2 regulates YAP1 to maintain stemness and determine cell fate in the osteo-adipo lineage. Cell Rep (2013) 1.07
Fibroblast growth factor 2 is necessary for the growth of glutamate projection neurons in the anterior neocortex. J Neurosci (2002) 1.02
Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. J Cell Physiol (2006) 1.02
Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage. Mol Cell Biol (2011) 1.00
Perspectives on cancer stem cells in osteosarcoma. Cancer Lett (2012) 0.97
Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts. Mol Cell Biol (2008) 0.96
Identification of active transcriptional regulatory modules by the functional assay of DNA from nucleosome-free regions. Genome Res (2008) 0.96
Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome. Dev Biol (2012) 0.95
Overexpression of cyclin E/CDK2 complexes overcomes FGF-induced cell cycle arrest in the presence of hypophosphorylated Rb proteins. Cell Cycle (2012) 0.94
Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction. J Mol Cell Cardiol (2009) 0.93
Regulation of cranial morphogenesis and cell fate at the neural crest-mesoderm boundary by engrailed 1. Development (2012) 0.89
A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins. Dev Biol (2004) 0.88
The structural nature of chromosomal instability in colon cancer cells. FASEB J (2002) 0.83
Molecular studies on the roles of Runx2 and Twist1 in regulating FGF signaling. Dev Dyn (2012) 0.83
The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic mice. Bone (2011) 0.82
Regulation of non-classical FGF1 release and FGF-dependent cell transformation by CBF1-mediated notch signaling. J Cell Physiol (2011) 0.80
The B55α regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes. Mol Cell Biol (2013) 0.79
FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes. Cell Cycle (2010) 0.77
Isolation and analysis of DNA derived from nucleosome-free regions. Methods Mol Biol (2013) 0.77
Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer. Oncotarget (2017) 0.75